Effect of VeSTAL Device in Type 2 Diabetes Mellitus

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 3, 2020

Primary Completion Date

January 22, 2021

Study Completion Date

January 22, 2021

Conditions
Type 2 DiabetesMetabolic Syndrome
Interventions
DEVICE

Vestal Device

Vestibular nerve stimulator

DEVICE

Placebo device

Sham nerve stimulator

Trial Locations (1)

Unknown

St Vincents Hospital, Dublin

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Compliance Solutions Ltd.

INDUSTRY

collaborator

University College Dublin

OTHER

collaborator

Exploristics Ltd

UNKNOWN

lead

Neurovalens Ltd.

INDUSTRY